SSRIs do lower the risk of further depressive episodes.
"To conclude, this review provides evidence that continuing SSRIs for 1 year reduces risk of MDD and relapse."
"To conclude, this review provides evidence that continuing SSRIs for 1 year reduces risk of MDD and relapse."